Side effects associated with hyperadrenocorticism, including characteristics of Cushing’s syndrome, were described during short-term, high-dose (ranging from 100 to 160 mg/day) daily ACTH treatment, but resolved following ACTH cessation [14, 32, 33, 36]. This evidence concerns the gene POMC and Cushing syndrome due to macronodular adrenal hyperplasia.